Phantom Neuro Secures $19M To Advance Human-Machine Muscle Memory
Phantom Neuro, an Austin, Texas-based neurotechnology startup spun out of Johns Hopkins University School of Medicine, has secured an oversubscribed $19 million Series A funding round, bringing its total funding to $28 million, announced on April 15, 2025.
How Phantom Neuro Integrates Muscle Memory in AI Prosthetics
Phantom Neuro’s Phantom X platform integrates muscle memory by implanting a small electrode array under the skin over residual muscles, capturing natural neural signals generated when users intend to move.
These electromyographic signals, processed through AI algorithms, enable the prosthetic to learn and adapt to the user’s unique patterns, replicating intuitive control akin to biological limbs. In a recent ASCENT study, the system achieved 94% accuracy across 11 hand and wrist movements, allowing non-invasive adaptation without extensive retraining.
Phantom Neuro’s Tech vs. elon musk's neuralink
The $19 million Series A, closed in April 2025, values Phantom Neuro as a key player in neurotech, enabling acceleration of its Phantom X platform from prototype to clinical trials.
Ottobock’s leadership investment, with a board seat for its CFO Dr. Arne Kreitz, underscores strategic alignment in prosthetics commercialization. The capital will fund outpatient-implantable electrode arrays that detect electromyographic (EMG) signals from residual muscles, translating them via AI into precise prosthetic commands.
This funding builds on prior seed rounds, positioning the company to extend applications beyond prosthetics to robotics and exoskeletons, in a sector where neural interfaces could reduce user training time by 50%.
Future Prospects for Phantom Neuro When can you Expect it to hit market
Experts praise Phantom Neuro’s approach for its minimally invasive nature and high accuracy, with Dr. Arne Kreitz noting its potential to lead prosthetics markets by providing effective, patient-centered solutions.
Researchers highlight the technology’s role in revolutionizing rehab, where AI-driven adaptation could shorten recovery by 25% through natural muscle retraining.
What is Phantom Neuro and its main technology?
An
Austin-tech-based neurotech firm developing the Phantom X neural interface for intuitive prosthetic control using muscle signals spun out of Johns Hopkins in 2021.
Who led the $19M Series A funding round?
Phantom Neuro’s $19 million Series A funding in April 2025, led by Ottobock, accelerates its Phantom X platform, integrating AI and muscle memory for 94% accurate neural control in prosthetics.
With total funding at $28 million and trials slated for 2026, the company is set to transform human-machine interfaces in a $12.3 billion market by 2030, enhancing autonomy for amputees and beyond. This milestone, backed by DARPA and FDA progress, promises profound quality-of-life improvements and innovation in rehab and robotics. For more on neurotech advancements, visit Objectwire.org.
Contact Us
